# Identification and histological validation of autophagy-related core genes ADRB2 and PLK2 in keloids, with integrated immune infiltration analysis

**Authors:** Junjie Jin, Yue Jin, Bo Lu, Zhehu Jin

PMC · DOI: 10.3389/fimmu.2026.1724230 · Frontiers in Immunology · 2026-02-09

## TL;DR

This study identifies ADRB2 and PLK2 as key autophagy-related genes in keloids, linking them to immune changes and fibrosis, with potential for diagnosis and treatment.

## Contribution

The study introduces ADRB2 and PLK2 as novel autophagy-related biomarkers in keloids, validated through histology and immune infiltration analysis.

## Key findings

- ADRB2 and PLK2 show significantly higher expression in keloid tissues compared to normal skin.
- These genes are associated with fibrotic and autophagy markers in keloid fibroblasts.
- Autophagy modulation affects ADRB2 but not PLK2 expression in keloid cells.

## Abstract

Keloids are pathological fibroproliferative scars characterized by excessive collagen deposition and a lack of effective targeted therapies. Autophagy dysregulation has been linked to keloid pathogenesis, but the underlying molecular mechanisms remain unclear.

Transcriptomic datasets were integrated and analyzed using differential expression analysis and weighted gene co-expression network analysis. Three machine learning algorithms—least absolute shrinkage and selection operator (LASSO), support vector machine–recursive feature elimination (SVM-RFE), and random forest—were applied to identify autophagy-related hub gene candidates in keloids. Immune infiltration and functional analyses were conducted to explore immune microenvironment alterations. Histological staining (H&E and Masson), immunohistochemistry, and Western blotting were used for tissue-level validation, while cellular experiments were performed in keloid fibroblasts with autophagy modulation.

ADRB2 and PLK2 were consistently identified as key autophagy-related candidate genes. Immune-related analyses suggested that these genes may be involved in remodeling the keloid immune microenvironment by influencing the abundance and functional status of multiple immune cell subsets. Histological and protein-level assays demonstrated significantly higher expression of ADRB2 and PLK2 in keloid tissues compared with adjacent normal skin. In keloid fibroblasts, fibrotic markers (COL1/COL3) and autophagy-related markers (LC3-II/LC3-I and p62) were upregulated concomitantly with ADRB2 and PLK2 at baseline. Autophagy modulation altered ADRB2 expression (decreased with EBSS and increased with chloroquine), whereas PLK2 expression remained largely unchanged.

These findings identify ADRB2 and PLK2 as under-recognized autophagy- andimmunity-related candidate biomarkers in keloids, highlighting their potential relevance asdiagnostic indicators and future therapeutic research targets.

## Linked entities

- **Genes:** ADRB2 (adrenoceptor beta 2) [NCBI Gene 154], PLK2 (polo like kinase 2) [NCBI Gene 10769], COL1 (CONSTANS-like 1) [NCBI Gene 831442], col-3 (Nematode cuticle collagen N-terminal domain-containing protein) [NCBI Gene 177695], Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 362245], Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 362245], GTF2H1 (general transcription factor IIH subunit 1) [NCBI Gene 2965]
- **Chemicals:** chloroquine (PubChem CID 2719)

## Full-text entities

- **Genes:** SLC7A5 (solute carrier family 7 member 5) [NCBI Gene 8140] {aka 4F2LC, CD98, D16S469E, E16, LAT1, MPE16}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CCL22 (C-C motif chemokine ligand 22) [NCBI Gene 6367] {aka A-152E5.1, ABCD-1, DC/B-CK, MDC, SCYA22, STCP-1}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}, QSOX1 (quiescin sulfhydryl oxidase 1) [NCBI Gene 5768] {aka Q6, QSCN6}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, SNCAIP (synuclein alpha interacting protein) [NCBI Gene 9627] {aka SYPH1, Sph1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, SVIP (small VCP interacting protein) [NCBI Gene 258010], EPAS1 (endothelial PAS domain protein 1) [NCBI Gene 2034] {aka ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73}, LEPR (leptin receptor) [NCBI Gene 3953] {aka CD295, LEP-R, LEPRD, OB-R, OBR, huB219}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, ADRB2 (adrenoceptor beta 2) [NCBI Gene 154] {aka ADRB2R, ADRBR, ARB2, B2AR, BAR, BETA2AR}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, PLK2 (polo like kinase 2) [NCBI Gene 10769] {aka SNK, hPlk2, hSNK}, PLIN2 (perilipin 2) [NCBI Gene 123] {aka ADFP, ADRP}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, KCNB1 (potassium voltage-gated channel subfamily B member 1) [NCBI Gene 3745] {aka DEE26, DRK1, Kv2.1}, PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 5563] {aka AMPK, AMPK2, AMPKa2, PRKAA}
- **Diseases:** Keloids (MESH:D007627), infection (MESH:D007239), fibrosis (MESH:D005355), fibrotic diseases (MESH:D004194), cutaneous injury (MESH:D014947), chronic inflammation (MESH:D007249), skin disorders (MESH:D012871), pain (MESH:D010146), hyperplasia (MESH:D006965), necrotic (MESH:D009336), intestinal fibrosis (MESH:D007410), systemic sclerosis (MESH:D012595), fibrotic disorders (MESH:D009358), pruritus (MESH:D011537), organic disease (MESH:D000092124)
- **Chemicals:** xylene (MESH:D014992), monodansylcadaverine (MESH:C008542), streptomycin (MESH:D013307), H&amp;E (MESH:D006371), Alexa Fluor 790 (-), H2O2 (MESH:D006861), paraffin (MESH:D010232), penicillin (MESH:D010406), aromatic amino acids (MESH:D024322), Hematoxylin (MESH:D006416), PVDF (MESH:C024865), SDS (MESH:D012967), DAB (MESH:C000469), eosin (MESH:D004801), PBS (MESH:D007854), phosphomolybdic acid (MESH:C003125), CQ (MESH:D002738), glucose (MESH:D005947), ethanol (MESH:D000431), formalin (MESH:D005557), citrate (MESH:D019343), CO2 (MESH:D002245), aniline blue (MESH:C017006), paraformaldehyde (MESH:C003043)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** C3019S, serine/threonine, AUC of 0
- **Cell lines:** CRL- — Sigmodon hispidus (Hispid cotton rat), Spontaneously immortalized cell line (CVCL_YD58)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926160/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926160/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926160/full.md

---
Source: https://tomesphere.com/paper/PMC12926160